Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2021-09-15 00:00:00 ET · period of report 2021-09-13 · accession 0001708138-21-000082 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-09-15 | 2021-09-13 | REGN | BROWN MICHAEL S | Dir | S - Sale+OE | $648.16 | -9,704 | 6,465 | -60% | -$6.29M |
| DM | 2021-09-15 | 2021-09-13 | REGN | BROWN MICHAEL S | Dir | M - OptEx | $405.06 | +9,704 | 10.6K | +1,089% | +$3.93M |
| DM | 2021-09-15 | 2021-09-13 | REGN | BROWN MICHAEL S | Dir | M - OptEx | $0.00 | -9,704 | 3,612 | -73% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-13 | S | D | 400 | $642.62 | 8,816 | D | — | — | (F5) Represents volume-weighted average price of sales of 400 shares of Company stock on September 13, 2021 at prices ranging from $642.36 to $642.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price. |
| 2 | Common | Common Stock | 2021-09-13 | M | A | 2,479 | $380.95 | 3,370 | D | — | — | |
| 3 | Common | Common Stock | 2021-09-13 | S | D | 62 | $652.26 | 891 | D | — | — | |
| 4 | Common | Common Stock | 2021-09-13 | S | D | 3,712 | $651.10 | 953 | D | — | — | (F10) Represents volume-weighted average price of sales of 3,712 shares of Company stock on September 13, 2021 at prices ranging from $651.10 to $651.21. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price. |
| 5 | Common | Common Stock | 2021-09-13 | S | D | 1,800 | $650.40 | 4,665 | D | — | — | (F9) Represents volume-weighted average price of sales of 1,800 shares of Company stock on September 13, 2021 at prices ranging from $650.19 to $650.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price. |
| 6 | Common | Common Stock | 2021-09-13 | M | A | 3,613 | $413.33 | 6,983 | D | — | — | |
| 7 | Common | Common Stock | 2021-09-13 | M | A | 3,612 | $413.33 | 10,595 | D | — | — | |
| 8 | Common | Common Stock | 2021-09-13 | S | D | 100 | $636.74 | 10,495 | D | — | — | |
| 9 | Common | Common Stock | 2021-09-13 | S | D | 200 | $637.29 | 10,295 | D | — | — | (F2) Represents volume-weighted average price of sales of 200 shares of Company stock on September 13, 2021 at prices ranging from $637.20 to $637.37. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price. |
| 10 | Common | Common Stock | 2021-09-13 | S | D | 676 | $638.64 | 9,619 | D | — | — | (F3) Represents volume-weighted average price of sales of 676 shares of Company stock on September 13, 2021 at prices ranging from $638.16 to $638.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price. |
| 11 | Common | Common Stock | 2021-09-13 | S | D | 203 | $639.20 | 9,416 | D | — | — | (F4) Represents volume-weighted average price of sales of 203 shares of Company stock on September 13, 2021 at prices ranging from $639.09 to $639.32. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price. |
| 12 | Common | Common Stock | 2021-09-13 | S | D | 100 | $640.77 | 9,316 | D | — | — | |
| 13 | Common | Common Stock | 2021-09-13 | S | D | 100 | $641.12 | 9,216 | D | — | — | |
| 14 | Common | Common Stock | 2021-09-13 | S | D | 100 | $643.49 | 8,716 | D | — | — | |
| 15 | Common | Common Stock | 2021-09-13 | S | D | 100 | $644.89 | 8,616 | D | — | — | |
| 16 | Common | Common Stock | 2021-09-13 | S | D | 100 | $645.66 | 8,516 | D | — | — | |
| 17 | Common | Common Stock | 2021-09-13 | S | D | 100 | $646.28 | 8,416 | D | — | — | |
| 18 | Common | Common Stock | 2021-09-13 | S | D | 151 | $647.58 | 8,265 | D | — | — | (F6) Represents volume-weighted average price of sales of 151 shares of Company stock on September 13, 2021 at prices ranging from $647.42 to $647.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price. |
| 19 | Common | Common Stock | 2021-09-13 | S | D | 962 | $648.48 | 7,303 | D | — | — | (F7) Represents volume-weighted average price of sales of 962 shares of Company stock on September 13, 2021 at prices ranging from $648.30 to $648.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price. |
| 20 | Common | Common Stock | 2021-09-13 | S | D | 838 | $649.46 | 6,465 | D | — | — | (F8) Represents volume-weighted average price of sales of 838 shares of Company stock on September 13, 2021 at prices ranging from $649.00 to $649.57. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price. |
| 21 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-09-13 | M | D | 3,612 | $0.00 | 0 | D | $413.33 · — to 2025-01-02 | 3,612 Common Stock | (F12) The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. |
| 22 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-09-13 | M | D | 2,479 | $0.00 | 0 | D | $380.95 · — to 2028-01-02 | 2,479 Common Stock | (F12) The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. |
| 23 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-09-13 | M | D | 3,613 | $0.00 | 3,612 | D | $413.33 · — to 2025-01-02 | 3,613 Common Stock | (F12) The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. |